Hanafy NAN - Search Results

1

Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells.

Hanafy NAN, Quarta A, Di Corato R, Dini L, Nobile C, Tasco V, Carallo S, Cascione M, Malfettone A, Soukupova J, Rinaldi R, Fabregat I, Leporatti S. Hanafy NAN, et al. J Mater Sci Mater Med. 2017 Aug;28(8):120. doi: 10.1007/s10856-017-5930-7. Epub 2017 Jul 6. J Mater Sci Mater Med. 2017. PMID: 28685231

2

Development and application of naturally derived, cost-effective CQDs with cancer targeting potential.

El-Borlsy H, Hanafy NAN, El-Kemary MA. El-Borlsy H, et al. Among authors: hanafy nan. Cell Biol Int. 2023 Apr;47(4):808-822. doi: 10.1002/cbin.11986. Epub 2023 Jan 14. Cell Biol Int. 2023. PMID: 36640423

3

Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy.

Hanafy NAN, El-Kemary M, Leporatti S. Hanafy NAN, et al. Cancers (Basel). 2018 Jul 20;10(7):238. doi: 10.3390/cancers10070238. Cancers (Basel). 2018. PMID: 30037052 Free PMC article. Review.

4

Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their Functionalization.

Hanafy NAN, Fabregat I, Leporatti S, Kemary ME. Hanafy NAN, et al. Pharmaceutics. 2020 May 2;12(5):421. doi: 10.3390/pharmaceutics12050421. Pharmaceutics. 2020. PMID: 32370293 Free PMC article.

5

Mucoadhesive curcumin crosslinked carboxy methyl cellulose might increase inhibitory efficiency for liver cancer treatment.

Hanafy NAN, Leporatti S, El-Kemary M. Hanafy NAN, et al. Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111119. doi: 10.1016/j.msec.2020.111119. Epub 2020 May 28. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32806233

6

Extraction of chlorophyll and carotenoids loaded into chitosan as potential targeted therapy and bio imaging agents for breast carcinoma.

Hanafy NAN, Leporatti S, El-Kemary MA. Hanafy NAN, et al. Int J Biol Macromol. 2021 Jul 1;182:1150-1160. doi: 10.1016/j.ijbiomac.2021.03.189. Epub 2021 Apr 15. Int J Biol Macromol. 2021. PMID: 33865895

7

Starch-Based Hydrogel Nanoparticles Loaded with Polyphenolic Compounds of Moringa Oleifera Leaf Extract Have Hepatoprotective Activity in Bisphenol A-Induced Animal Models.

Abou El-Naga HMH, El-Hashash SA, Yasen EM, Leporatti S, Hanafy NAN. Abou El-Naga HMH, et al. Among authors: hanafy nan. Polymers (Basel). 2022 Jul 13;14(14):2846. doi: 10.3390/polym14142846. Polymers (Basel). 2022. PMID: 35890622 Free PMC article.

8

Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl₄-Induced Liver Fibrosis in Rats.

Panzarini E, Leporatti S, Tenuzzo BA, Quarta A, Hanafy NAN, Giannelli G, Moliterni C, Vardanyan D, Sbarigia C, Fidaleo M, Tacconi S, Dini L. Panzarini E, et al. Among authors: hanafy nan. J Pers Med. 2022 Nov 1;12(11):1812. doi: 10.3390/jpm12111812. J Pers Med. 2022. PMID: 36579532 Free PMC article.

9

Simultaneous Administration of Bevacizumab with Bee-Pollen Extract-Loaded Hybrid Protein Hydrogel NPs Is a Promising Targeted Strategy against Cancer Cells.

Hanafy NAN, Eltonouby EAB, Salim EI, Mahfouz ME, Leporatti S, Hafez EH. Hanafy NAN, et al. Int J Mol Sci. 2023 Feb 10;24(4):3548. doi: 10.3390/ijms24043548. Int J Mol Sci. 2023. PMID: 36834960 Free PMC article.

10

Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.

Hanafy NAN. Hanafy NAN. Int J Biol Macromol. 2021 Jul 1;182:1981-1993. doi: 10.1016/j.ijbiomac.2021.05.149. Epub 2021 May 28. Int J Biol Macromol. 2021. PMID: 34058209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters